Who Owns BCTXW?

BriaCell Therapeutics Corp. Warrant — Institutional Ownership & 13F Holdings

$0.00

+0.00 (+0.00%)

Market Cap

$3K

Shares Outstanding

Institutional Holders

7

Total Inst. Value

$15K

% of Float Held

QoQ Holder Change

+4

Institutional data as of Q1 2025

New Positions

7

Closed Positions

0

Increased

0

Decreased

0

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Redmond Asset Management, LLCNew$8K75,000
2TWO SIGMA SECURITIES, LLCNew$3K30,838
3ARMISTICE CAPITAL, LLCNew$3K25,000
4SUSQUEHANNA INTERNATIONAL GROUP, LLPNew$1K16,246
5UBS Group AGNew$2742,689
6OSAIC HOLDINGS, INC.New$72800
7CLEAR STREET LLCNew$10100

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue

Related Stocks

Frequently Asked Questions

How many institutional investors hold BCTXW?

As of Q1 2025, 7 institutional investors report holding BCTXW (BriaCell Therapeutics Corp. Warrant) in their 13F filings.

Which hedge fund owns the most BCTXW?

The largest institutional holder of BCTXW is Redmond Asset Management, LLC with $8K in shares.

Are institutions buying or selling BCTXW?

This quarter, 7 institutions opened new positions in BCTXW and 0 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.